← Browse by Condition
Medical Condition
cervical cancer
Total Trials
36
Recruiting Now
36
Trial Phases
Phase 3, Phase 2, Phase 1, Phase 2
NCT05808933
Recruiting
Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer
Enrollment
150 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT06276309
Recruiting
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Enrollment
300 pts
Location
China
Sponsor
Fujian Maternity and Child Hea...
NCT06459687 Phase 3
Recruiting
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Enrollment
440 pts
Location
China
Sponsor
Lee's Pharmaceutical Limited
NCT04831580
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Enrollment
840 pts
Location
United States, Canad...
Sponsor
GOG Foundation
NCT07167160 Phase 2
Recruiting
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Enrollment
59 pts
Location
China
Sponsor
Women's Hospital School Of Med...
NCT06489795
Recruiting
German-funded Laparoscopic Approach to Cervical Cancer
Enrollment
756 pts
Location
Germany
Sponsor
Hannover Medical School
NCT06253169
Recruiting
HPV DNA Self-sampling in a General Practitioner's Office.
Enrollment
2,000 pts
Location
Czechia
Sponsor
Patient Organization Veronica
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT06973161
Recruiting
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Enrollment
105 pts
Location
United States, Austr...
Sponsor
AstraZeneca
NCT07298642 Phase 2, Phase 3
Recruiting
Extended-field Proton Therapy for Cervical Cancer
Enrollment
44 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT07181720 Phase 1
Recruiting
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Enrollment
90 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
NCT07050745
Recruiting
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Enrollment
1,980 pts
Location
Kenya
Sponsor
Kenyatta National Hospital
NCT06508307 Phase 1
Recruiting
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Enrollment
21 pts
Location
China
Sponsor
GONGCHU Biotechnology Co., Ltd
NCT05554276 Phase 2
Recruiting
Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer
Enrollment
36 pts
Location
China
Sponsor
Shanghai Jiao Tong University ...
NCT06458062
Recruiting
Pocket Colposcopy Using CARE Algorithm
Enrollment
1,079 pts
Location
Kenya
Sponsor
Duke University
NCT05062707
Recruiting
Early Ageing During Therapy in AYA Cancer Patients
Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
NCT05990803 Phase 2
Recruiting
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies
Enrollment
130 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
NCT07054567 Phase 2
Recruiting
A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
Enrollment
96 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
NCT06004011
Recruiting
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
Enrollment
4,100 pts
Location
Zambia
Sponsor
Implenomics
NCT07202364 Phase 2
Recruiting
A Study of YL202 in Patients With Advanced Solid Tumors
Enrollment
100 pts
Location
China
Sponsor
MediLink Therapeutics (Suzhou)...
NCT05283421
Recruiting
Improving Diagnostics in Cervical Dysplasia
Enrollment
150 pts
Location
Denmark
Sponsor
University of Aarhus
NCT05610501
Recruiting
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Enrollment
200 pts
Location
Belgium, Czechia, It...
Sponsor
Universitaire Ziekenhuizen KU ...
NCT03476681 Phase 1, Phase 2
Recruiting
Study of NEO-201 in Solid Tumors Expansion Cohorts
Enrollment
121 pts
Location
United States
Sponsor
Precision Biologics, Inc
NCT07092007
Recruiting
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
Enrollment
18 pts
Location
China
Sponsor
Newish Technology (Beijing) Co...
NCT06082765
Recruiting
Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
Enrollment
10,000 pts
Location
China
Sponsor
Zhongnan Hospital
NCT04512144
Recruiting
Mindfulness in Endometrial and Cervical Cancer
Enrollment
120 pts
Location
United States
Sponsor
St. Louis University
NCT05914974
Recruiting
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Enrollment
120 pts
Location
Germany
Sponsor
University Hospital Tuebingen
NCT06433817
Recruiting
Spectral CT in Radiotherapy for Cervical Cancer
Enrollment
150 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT06771193
Recruiting
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
Enrollment
200 pts
Location
Italy
Sponsor
MSD Italia S.r.l.
NCT06769152 Phase 2
Recruiting
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
Enrollment
130 pts
Location
China
Sponsor
Shanghai Henlius Biotech
NCT03997110
Recruiting
Palliative Radiation for Advanced Cervical Cancer
Enrollment
230 pts
Location
India
Sponsor
Tata Memorial Hospital
NCT05838521 Phase 2
Recruiting
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
Enrollment
20 pts
Location
United States
Sponsor
Yale University
NCT06289062 Phase 2
Recruiting
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Enrollment
40 pts
Location
China
Sponsor
Tongji Hospital
NCT04916990
Recruiting
Improving Care for Rural Patients With Solid Tumors
Enrollment
320 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT03853915
Recruiting
FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
Enrollment
64 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT06251947 Phase 2
Recruiting
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Enrollment
83 pts
Location
China
Sponsor
Shandong University